Abstract:OBJECTIVE—The key pancreatic transcription factor pancreatic duodenal homeobox-1 (Pdx1), known to control development and maintenance of pancreatic β-cells, possesses a protein transduction domain (PTD) that facilitates its entry into cells. We therefore sought to evaluate the capacity of in vivo–administered recombinant Pdx1 (rPdx1) to ameliorate hyperglycemia in mice with streptozotocin-induced diabetes. RESEARCH DESIGN AND METHODS—Cell entry and transcriptional regulatory properties of rPdx1 protein and its PTD-deletion mutant rPdx1Δ protein, as well as a PTD–green fluorescent protein, were evaluated in vitro. After intraperitoneal rPdx1 injection into mice with streptozotocin-induced diabetes, we assessed its action on blood glucose levels, insulin content, intraperitoneal glucose tolerance test (IPGTT), Pdx1 distribution, pancreatic gene expression, islet cell proliferation, and organ histology. RESULTS—Restoration of euglycemia in Pdx1-treated diabetic mice was evident by improved IPGTT and glucose-stimulated insulin release. Insulin, glucagon, and Ki67 immunostaining revealed increased islet cell number and proliferation in pancreata of rPdx1-treated mice. Real-time PCR of pancreas and liver demonstrated upregulation of INS and PDX1 genes and other genes relevant to pancreas regeneration. While the time course of β-cell gene expression and serum/tissue insulin levels indicated that both liver- and pancreas-derived insulin contributed to restoration of normoglycemia, near-total pancreatectomy resulted in hyperglycemia, suggesting that β-cell regeneration played the primary role in rPdx1-induced glucose homeostasis. CONCLUSIONS—rPdx1 treatment of mice with streptozotocin-induced diabetes promotes β-cell regeneration and liver cell reprogramming, leading to restoration of normoglycemia. This novel PTD-based protein therapy offers a promising way to treat patients with diabetes while avoiding potential side effects associated with the use of viral vectors.

Andrographolide Promotes Pancreatic Duct Cells Differentiation into Insulin-Producing Cells by Targeting PDX-1.

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

A Saponin from Astragalus Promotes Pancreatic Ductal Organoids Differentiation into Insulin-Producing Cells.

Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats

Generation of Insulin-Producing Cells from Bone Marrow Mesenchymal Stem Cells with Modified Expression of PDX1 and NKX6.1

In Vitropancreas Duodenal Homeobox-1 Enhances the Differentiation of Pancreatic Ductal Epithelial Cells into Insulin-Producing Cells

PDX-1 Mrna-Induced Reprogramming of Mouse Pancreas-Derived Mesenchymal Stem Cells into Insulin-Producing Cells in Vitro

Chemical Strategies for Pancreatic Β Cell Differentiation, Reprogramming, and Regeneration

Transcription Factor Directed Differentiation of Human Embryonic Stem Cells into the Pancreatic Endocrine Lineage

Pdxl and its role in activating Ngn3 and Pax6 to induce differentiation of iPSCs into islet β cells

123. rAAV-pdx-1 Augmented the Insulin-Producing Cells

Direct Differentiation of Hepatic Stem-Like WB Cells into Insulin-Producing Cells Using Small Molecules

Adeno-associated Virus-Mediated Pancreatic and Duodenal Homeobox Gene 1 Delivery Induced Insulin-Producing Cells in Livers of Diabetic Rats

Morphological Characteristics and Identification of Islet-Like Cells Derived from Rat Adipose-Derived Stem Cells Cocultured with Pancreas Adult Stem Cells

A small-molecule inducer of PDX1 expression identified by high-throughput screening

Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction with Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1

Generation of Insulin-Producing Cells from PDX1 and NKX6.1 Gene-Modified Bone Marrow Mesenchymal Stem Cells

Specific Reprogramming of Alpha Cells to Insulin-Producing Cells by Short Glucagon Promoter-Driven Pdx1 and MafA

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors

The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells.

Studies on insulin-producing cells induced from mouse adipose mesenchymal stem cells